2-Chloromethylbenzimidazole → 5-(2-benzimidazolylmethyloxy)-10-bromo-2-(3-pyridylmethyl)-3H-pyrido [3,2,1-kl]phenothiazin-3-one
반응식
[Br:1][C:2]1[CH:15]=[CH:14][C:13]2[S:12][C:11]3[C:6]4=[C:7]([C:17](=[O:27])[C:18]([CH2:20][C:21]5[CH:22]=[N:23][CH:24]=[CH:25][CH:26]=5)=[CH:19][N:5]4[C:4]=2[CH:3]=1)[CH:8]=[C:9]([OH:16])[CH:10]=3.Cl[CH2:29][C:30]1[NH:31][C:32]2[CH:38]=[CH:37][CH:36]=[CH:35][C:33]=2[N:34]=1>>[N:31]1[C:32]2[CH:38]=[CH:37][CH:36]=[CH:35][C:33]=2[NH:34][C:30]=1[CH2:29][O:16][C:9]1[CH:10]=[C:11]2[C:6]3=[C:7]([C:17](=[O:27])[C:18]([CH2:20][C:21]4[CH:22]=[N:23][CH:24]=[CH:25][CH:26]=4)=[CH:19][N:5]3[C:4]3[CH:3]=[C:2]([Br:1])[CH:15]=[CH:14][C:13]=3[S:12]2)[CH:8]=1참가 물질
3
실험 절차
According to Example 34, the compound (500 mg) produced in Example 37 was reacted with 2-chloromethylbenzimidazole (243 mg) to obtain the title compound (10 mg; 0.2%).
출처 및 근거
- ORD 기록
- ord-0347b9f803ba46a781db3b21cce739ed
- 출처 데이터셋
- uspto-grants-2002_11
- DOI